<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38558899</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0034-6233</ISSN><JournalIssue CitedMedium="Print"><Volume>62</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Reumatologia</Title><ISOAbbreviation>Reumatologia</ISOAbbreviation></Journal><ArticleTitle>Symptom intensity of post-COVID and long COVID syndromes in patients entering rehabilitation treatment.</ArticleTitle><Pagination><StartPage>18</StartPage><EndPage>25</EndPage><MedlinePgn>18-25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5114/reum/183912</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">The problem of post-COVID symptoms is still being analysed. Many of them may be related to other conditions, but the new appearance and greater intensity of some of them, e.g. fatigue, musculoskeletal pain, and neuropathic pain, seem to be related to a previous viral infection. Efforts are being made to determine in more detail the most characteristic symptoms of post-COVID syndrome. The conditions of rehabilitation after COVID-19 provide an opportunity for such observations. In rehabilitation centres and sanatoriums, it is possible to compare patients with post-COVID syndrome and other patients referred for rehabilitation, who constitute a natural control group. Such a comparison is the aim of the present work.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="UNASSIGNED">The study included 59 post-COVID-19 patients and 57 sanatorium patients without COVID (non-COVID group) as a control group. The 31-element questionnaire ("Post-COVID syndrome symptoms assessment card") was part of the routine management of post-COVID patients referred for rehabilitation after symptomatic SARS-CoV-2 infection in Polish conditions. In the control group, the questionnaire was introduced as a part of a physical examination and an interview regarding the symptoms reported by the patient before standard rehabilitation. The questions were scored in the scale from 0 to a maximum of 10 points. Each patient gave informed consent to the use of the questionnaire for research purposes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Symptoms of the highest intensity in the COVID-19 group were: feeling unwell after physical effort (avg. 6.25 points), chronic fatigue (avg. 5.97 points), dyspnoea on exertion (avg. 5.83 points), concentration disturbances (avg. 4.93), muscle pain (avg. 4.92), joint pain (avg. 4.86), memory disorders (avg. 4.81 points), sleep disorders (avg. 4.05 points), numbness of the limbs (avg. 3.73 points), tingling in the limbs (avg. 3.68 points).Symptoms of highest intensity in patients in the non-COVID-19 group: joint pain (avg. 4.61 points), tingling in the limbs (avg. 2.84 points), numbness of the limbs (avg. 2.79 points), muscle pain (avg. 2.11 points).There was no statistically significant difference between the group under examination and the control group in the following symptoms: fever, diarrhoea, abdominal pain, resting dyspnoea, olfactory disorders, joint pain, tingling in the limbs and numbness of the limbs.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The results of this study show symptoms of the highest intensity with post-COVID syndromes. However, also symptoms that are a problem both in post-COVID and non-COVID patients, i.e. joint pain, tingling in and numbness of the limbs were identified. This confirms that the control non-COVID group consisted of patients referred for rehabilitation treatment mainly due to musculoskeletal problems and chronic pain.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ceklarz</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2752-8393</Identifier><AffiliationInfo><Affiliation>Department of Systemic Rehabilitation, Rabka Sanatorium, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Reumatologia</MedlineTA><NlmUniqueID>20130190R</NlmUniqueID><ISSNLinking>0034-6233</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID rehabilitation</Keyword><Keyword MajorTopicYN="N">symptom intensity</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>17</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38558899</ArticleId><ArticleId IdType="pmc">PMC10979377</ArticleId><ArticleId IdType="doi">10.5114/reum/183912</ArticleId><ArticleId IdType="pii">183912</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stoian M, Procopiescu B, &#x218;eitan S, Scarlat G. Post-COVID-19 syndrome: Insights into a nov-el post-infectious systemic disorder. J Med Life 2023; 16: 195&#x2013;202, DOI: 10.25122/jml-2022-0329.</Citation><ArticleIdList><ArticleId IdType="doi">10.25122/jml-2022-0329</ArticleId><ArticleId IdType="pmc">PMC10015558</ArticleId><ArticleId IdType="pubmed">36937488</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou HC, Pavli A, Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines 2021; 9: 497, DOI: 10.3390/vaccines9050497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050497</ArticleId><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipiak K. Zespo&#x142;y post-COVID oraz long COVID &#x2013; pr&#xf3;ba systematyzacji. In: Pacjent post-COVID-owy. Co zostaje, a co si&#x119; zmienia? Ma&#x15b;li&#x144;ska M (ed.). Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji, Warszawa: 2021; 31&#x2013;36.</Citation></Reference><Reference><Citation>Clauw DJ, Calabrese L. Rheumatology and Long COVID: lessons from the study of fibromyalgia. Ann Rheum Dis 2024; 83: 136&#x2013;138, DOI: 10.1136/ard-2023-224250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2023-224250</ArticleId><ArticleId IdType="pmc">PMC10850638</ArticleId><ArticleId IdType="pubmed">37230736</ArticleId></ArticleIdList></Reference><Reference><Citation>MacPhie E, Coates LC. Long COVID: defining the role of rheumatology in care and research. Lancet Rheumatol 2022; 4: e812&#x2013;e814, DOI: 10.1016/S2665-9913(22)00266-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(22)00266-1</ArticleId><ArticleId IdType="pmc">PMC9529216</ArticleId><ArticleId IdType="pubmed">36211989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarz&#x105;dzenie Prezesa NFZ nr 98/2021/DSOZ z dnia 2.06.2021 r. [The Order of the President of the National Health Fund No. 98/2021/DSOZ of June 2, 2021]. [Document in Polish] (Access: 02.02.2024).</Citation></Reference><Reference><Citation>Wegrzynska K, Komiazyk M, Walory J, et al. . Differentiation of SARS-CoV-2 Variants Using RT-qPCRs by Targeting Recurrent Mutation Sites: A Diagnostic Laboratory Experience from Multi-Center Regional Study, August 2020&#x2013;December 2021, Poland. Inter J Molecul Sci 2022; 23: 9416, DOI: 10.3390/ijms23169416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23169416</ArticleId><ArticleId IdType="pmc">PMC9409138</ArticleId><ArticleId IdType="pubmed">36012683</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarz&#x105;dzenie Prezesa NFZ nr 172/2021/DSOZ z dnia 18.10.2021 r. [The Order of the President of the National Health Fund No. 172/2021/DSOZ of October 18, 2021]. [Document in Polish] (Access: 02.02.2024).</Citation></Reference><Reference><Citation>Lippi G, Sanchis-Gomar F, Henry BM. COVID-19 and its long-term sequelae: what do we know in 2023? Pol Arch Intern Med 2023; 133: 16402, DOI: 10.20452/pamw.16402</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16402</ArticleId><ArticleId IdType="pubmed">36626183</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wambeke E, Bezler C, Kasprowicz AM, et al. . Two-years follow-up of symptoms and return to work in complex post-COVID-19 patients. J Clin Med 2023; 12: 741, DOI: 10.3390/jcm12030741.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12030741</ArticleId><ArticleId IdType="pmc">PMC9917586</ArticleId><ArticleId IdType="pubmed">36769389</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Desai AD, Wan EY. Post-COVID-19 condition. Ann Rev Me 2023; 74: 55&#x2013;64, DOI: 10.1146/annurev-med-043021-030635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-030635</ArticleId><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackowiak PA, Chervenak FA, Gr&#xfc;nebaum A. Defining Fever. Open Forum Infect Dis 2021; 8: ofab161, DOI: 10.1093/ofid/ofab161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab161</ArticleId><ArticleId IdType="pmc">PMC8394829</ArticleId><ArticleId IdType="pubmed">34476283</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinical Medicine 2021; 38: 101019, DOI: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoy D, Bain C, Williams G, et al. . A systematic review of the global prevalence of low back pain. Arthritis Rheum 2012; 64: 2028&#x2013;2037, DOI: 10.1002/art.34347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34347</ArticleId><ArticleId IdType="pubmed">22231424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhassira D. Neuropathic pain: Definition, assessment and epidemiology. Rev Neurol (Paris) 2019; 175: 16&#x2013;25, DOI: 10.1016/j.neurol.2018.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2018.09.016</ArticleId><ArticleId IdType="pubmed">30385075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuciel-Lewandowska J, Kasperczak M, Lewandowski &#x141;B, Paprocka-Borowicz M. Assessment of the Level of Pain Intensity and the Level of Anxiety Treated as State and Trait in Patients with Osteoarthritis of the Limbs. Pain Res Manag 2020; 2020: 5904743, DOI: 10.1155/2020/5904743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5904743</ArticleId><ArticleId IdType="pmc">PMC7195646</ArticleId><ArticleId IdType="pubmed">32377287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>